COAG (Hemab Therapeutics Holdings, Inc. Common Stock) Stock Analysis - SEC Filings

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find COAG SEC filings?

Rallies organizes COAG SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

COAG Key Metrics

Key financial metrics for COAG
MetricValue
Price$26.47
Market Cap$1.27B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$36.61
52-Week Low$23.00
Volume206
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest COAG News

Recent COAG Insider Trades

  • RA CAPITAL MANAGEMENT, L.P. bought 6.39K (~$159.04K) on May 12, 2026.
  • RA CAPITAL MANAGEMENT, L.P. bought 14.15K (~$346.23K) on May 11, 2026.
  • RA CAPITAL MANAGEMENT, L.P. bought 25.72K (~$643.00K) on May 11, 2026.

COAG Analyst Consensus

COAG analyst coverage data. Average price target: $0.00.

Common questions about COAG

Where can I find COAG SEC filings?
Rallies organizes COAG SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show COAG 10-K and 10-Q filings?
Rallies organizes COAG SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is COAG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for COAG. It does not provide personalized investment advice.
COAG

COAG